Delivery Order SPE2DB22D2206-SPE2DB25FDV99

Award Date 10/18/24
Potential Completion Date 10/21/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $76,281.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA, is for the supply of Skyrizi 150 mg/ml injectable medication. The IDC, valued at $999,999,999, serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,701.39 Firm Fixed Price delivery order is for the supply of Skyrizi 150 mg/ml injectable medication. The contract has an ultimate completion date of October 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with an award value of $11,827.51, is a Delivery Order for the 360 mg/2.4 ml on-body medication Skyrizi. The contract has a firm fixed price pricing type and an ultimate completion date of November 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $12,236.27 firm fixed-price delivery order is for the supply of SKYRIZI 150 MG/ML PENML, with a completion date of December 24, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of SKYRIZI 150 MG/ML PENML, a pharmaceutical product. The firm-fixed-price delivery order, valued at $16,417.53, has a period of performance through March 26, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,744.99 firm fixed-price delivery order is for the medication Skyrizi 150 mg/ml, with a completion date of November 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $76,698.42 Firm Fixed Price delivery order is for the drug SKYRIZI 150 MG/ML PENML. The contract has an ultimate completion date of March 12, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award, valued at $131,555.83, was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for SKYRIZI 150 MG/ML PENML, a pharmaceutical product, with a period of performance through May 23, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order with a Firm Fixed Price valued at $13,836.91. The contract supports the supply of SKYRIZI 150 MG/ML PENML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award is not designated under any set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a $13,497.55 Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SKYRIZI 150 MG/ML syringes and does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FDV99
    Delivery Order

This federal contract award to AmerisourceBergen Drug Corp is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $13,325.60. The contract, which does not have a set-aside designation, is for the supply of Skyrizi 150 mg/mL injectable medication. AmerisourceBergen, a major pharmaceutical distributor, holds a significant $999,999,999 IDC with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 1/17/25, 9:23 AM